Rein Therapeutics Inc.
RNTX
$1.76
-$0.15-7.85%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -27.12% | -19.46% | 82.00% | -30.45% | 43.45% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -79.29% | 74.61% | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1.54% | 3,020.00% | 0.00% | -97.38% | 3,712.00% |
Total Current Assets | -26.91% | -19.32% | 81.44% | -30.12% | 42.78% |
|
|||||
Total Current Assets | -26.91% | -19.32% | 81.44% | -30.12% | 42.78% |
Net Property, Plant & Equipment | 0.00% | -50.00% | -66.67% | -68.42% | -34.48% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | -- |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | -- |
Total Other Intangibles | -46.72% | 0.00% | 0.00% | 0.00% | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | -99.72% | -20.52% | -59.33% | -- |
Total Assets | -40.33% | -4.74% | 10.29% | -6.43% | 726.77% |
|
|||||
Total Accounts Payable | -15.57% | 37.98% | -63.73% | 81.18% | 145.87% |
Total Accrued Expenses | 4.64% | 15.56% | 86.07% | -28.73% | 163.06% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 67.12% | -71.37% | -8.93% | 35.92% | 836.36% |
Total Other Current Liabilities | 67.12% | -71.37% | -8.93% | 35.92% | 836.36% |
Total Current Liabilities | 1.59% | 14.62% | 8.94% | 3.35% | 170.01% |
|
|||||
Total Current Liabilities | 1.59% | 14.62% | 8.94% | 3.35% | 170.01% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -38.39% | -3.37% | 3.49% | 0.00% | -- |
Total Liabilities | -13.21% | 7.23% | 6.63% | 1.91% | 374.82% |
|
|||||
Common Stock & APIC | 0.04% | 0.02% | 5.92% | 15.22% | 1.06% |
Retained Earnings | -13.20% | -1.92% | -3.02% | -2.47% | -2.61% |
Treasury Stock & Other | 30.77% | -18.18% | 65.08% | 0.00% | -- |
Total Common Equity | -81.31% | -10.33% | 25.18% | 549.77% | -38.50% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | -3.39% | -49.04% | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | -3.39% | -49.04% | -- |
|
|||||
Total Common Equity | -81.31% | -10.33% | 25.18% | 549.77% | -38.50% |
Total Preferred Equity | 0.00% | 0.00% | -3.39% | -49.04% | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -42.88% | -5.73% | 10.61% | -7.08% | 777.81% |
|